Background: Natalizumab is a monoclonal antibody directed against α₄ integrin used in the treatment of multiple sclerosis (MS). Four cases of melanomas occurring in patients prescribed natalizumab to treat MS were recently reported. Although some fundamental data suggested that α₄β1 integrin could be linked to the invasiveness of melanoma, none showed any relation with the transformation of melanocytes.
Observations: We performed a prospective follow-up of a cohort of patients with MS treated with natalizumab to assess the evolution of nevi under treatment. Clinical dermatologic examination and videodermoscopy were performed every 6 months. Nevi were compared side-by-side with baseline photographs, and histologic analysis was proposed based on clinical and dermoscopic criteria. Forty-four patients were included, and 248 nevi were examined and followed up. The mean duration of follow-up was 14 months (range, 6-20 months). Seventeen lesions (6.8%) showed modifications over time. Only 12 (4.8%) presented substantial dermoscopic changes. Five lesions were removed. All of them were classified as benign after histologic examination.
Conclusions: Our results showed the same rate of clinical and dermoscopic changes of nevi during treatment with natalizumab compared with the spontaneous evolution of nevi reported in literature. In accordance with fundamental data, those results suggest that the inhibition of the α₄ integrin does not promote the transformation of melanocytic lesions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archdermatol.2010.243 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cutaneous Nevoid Melanoma: A Retrospective Study on Clinico-Pathological Characteristics, with a Focus on Dermoscopic Features and Survival Analysis.
Cancers (Basel)
December 2024
Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
Diagnosis of nevoid melanoma (NeM) is often difficult because NeM closely resembles a common nevus clinically and histologically. A retrospective study was conducted on 110 patients diagnosed with and/or treated for primary nevoid melanoma at the Veneto Institute of Oncology and at the University Hospital of Padua from August 1999. Mean Breslow thickness was of 1.
View Article and Find Full Text PDFSuccessful Aflibercept Treatment for Choroidal Neovascularization in a Rare Case of Optic Disc Melanocytoma.
Am J Case Rep
December 2024
Department of Oncology-Ophthalmology, Curie Institute, Paris, France.
Article Synopsis
- Optic disc melanocytoma is a benign, usually asymptomatic tumor found in the eye, but it can lead to complications like choroidal neovascularization, which can be challenging to distinguish from malignant tumors.
- A case study of a 54-year-old man with optic disc melanocytoma showed the need for close monitoring due to growth, prompting treatment with anti-VEGF-A injections after development of neovascular membranes.
- Treatment with intravitreal anti-VEGF-A can effectively manage choroidal neovascularization related to optic disc melanocytoma and requires advanced imaging techniques for accurate diagnosis.
Integrating generative AI with ABCDE rule analysis for enhanced skin cancer diagnosis, dermatologist training and patient education.
Front Med (Lausanne)
October 2024
Hannover Centre for Optical Technologies, Leibniz University Hannover, Hannover, Germany.
Significance: The early detection and accurate monitoring of suspicious skin lesions are critical for effective dermatological diagnosis and treatment, particularly for reliable identification of the progression of nevi to melanoma. The traditional diagnostic framework, the ABCDE rule, provides a foundation for evaluating lesion characteristics by visual examination using dermoscopes. Simulations of skin lesion progression could improve the understanding of melanoma growth patterns.
View Article and Find Full Text PDFRapid Growth and Evolution of a Dysplastic Nevus During Pregnancy.
S D Med
December 2023
Department of Internal Medicine, University of South Dakota Sanford School of Medicine.
Article Synopsis
- * Conflicting research exists about how pregnancy affects melanocytic nevi and melanoma, although newer studies suggest that prognosis for pregnant patients with melanoma is not dangerously worse.
- * A case study of a 27-year-old woman highlights the evolution of two moles during her pregnancies, showing that some lesions can change without prior alterations in the intervening periods.
Melanoma in Pediatric and Young Adult Patients.
Curr Oncol Rep
July 2024
Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, U.S.A.
Article Synopsis
- Melanoma presents differently in younger patients compared to older individuals, with unique clinical features and prognosis that warrant specific attention.
- Recent advancements in molecular techniques help distinguish between true melanoma and atypical lesions like Spitz tumors, improving the accuracy of diagnosis in younger populations.
- While the treatment for confirmed melanoma in young individuals is similar to that in older patients, optimal strategies for atypical Spitz tumors remain unclear, emphasizing the need for better understanding and awareness for earlier detection and effective management.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!